The conglomerate beat analysts' operating profit target, but there were no share buybacks over the third quarter.

Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Berkshire Hathaway (BRK-B, BRK-A) stock is in focus after the company reported earnings. CFRA Research vice president of equity research Cathy Seifert discusses key takeaways from the earnings print, ...

Berkshire Hathaway posted strong Q3 earnings with rising profits, $400B cash, and steady valuation near 1.48x book. Learn why ...

Berkshire Hathaway reported major stock sales last quarter. That includes a further reduction in one of Berkshire's top ...

Narrow-moat-rated Berkshire Hathaway BRK.A BRK.B reported adjusted third-quarter operating results that were basically in ...

Investors have long followed Buffett and team's stock picks via a massive portfolio within Berkshire Hathaway. Today, that ...

Supreme Court arguments over tariffs are coming, shutdown milestone approaches, China’s EV sales are slowing, and more news ...

Despite Berkshire Hathaway being a net seller of stocks for the past three years, Warren Buffett would never sell these two dividend stocks.

Investors shouldn't replicate the concentration of Berkshire, but the following stocks could have a place in your portfolio.

Berkshire Hathaway signaled on Saturday that it remained cautious about markets, letting cash swell to a record $381.7 ...